Document Detail


Pharmacomodulation of high-density lipoprotein metabolism as a therapeutic intervention for atherosclerotic disease.
MedLine Citation:
PMID:  20740329     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The high-density lipoproteins (HDLs) are produced by the liver and small intestine as well as on the surface of lipid-enriched macrophages in the subendothelial space of arterial walls. Unlike the apo B100-containing lipoproteins, the HDLs are uniquely antiatherogenic. Based on prospective observational studies performed throughout the world, there is a consistent inverse relationship between serum levels of HDLs and risk for cardiovascular events: low levels of high-density lipoprotein-cholesterol (HDL-C) are associated with increased risk, whereas high levels are usually associated with reduced risk for myocardial infarction, ischemic stroke, and cardiovascular mortality. Post hoc analyses of a number of studies using statins and fibrates have shown that raising serum HDL-C correlates with a reduction in risk for cardiovascular morbidity and mortality. Given these observations, enormous resources are being committed to the development of novel means by which to pharmacologically increase rates of HDL biosynthesis, modulate the functionality of HDL, and to promote reverse cholesterol transport with intravenous infusions of HDL particles.
Authors:
Peter P Toth
Related Documents :
2177629 - Effect of a cholesterol synthesis inhibitor (bm 15.766) in the presence and absence of ...
20198309 - Classification of hypocholesterolemia lipid patterns using chol/trig combination system.
19761869 - Apolipoprotein c-i reduces cholesteryl esters selective uptake from ldl and hdl by bind...
20480549 - High-density lipoprotein heterogeneity and function in reverse cholesterol transport.
12733749 - Effects of policosanols and phytosterols on lipid levels and cholesterol biosynthesis i...
12573359 - Atp-binding cassette a1 protein and hdl homeostasis.
3367239 - Availability to chicks of biotin from dried egg products.
11225179 - Health benefits of dietary fat reduction by a novel fat replacer: mimix.
3987969 - The role of feeding regimens in the growth of neonate broad-banded water snakes, nerodi...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current cardiology reports     Volume:  12     ISSN:  1534-3170     ISO Abbreviation:  Curr Cardiol Rep     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-09-15     Completed Date:  2010-12-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100888969     Medline TA:  Curr Cardiol Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  481-7     Citation Subset:  IM    
Affiliation:
Sterling Rock Falls Clinic, 101 East Miller Road, Sterling, IL 61081, USA. peter.toth@srfc.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Arteriosclerosis / drug therapy*
Cholesterol Ester Transfer Proteins / antagonists & inhibitors
Cholesterol, HDL / drug effects*,  metabolism
Humans
Hypolipidemic Agents / pharmacology,  therapeutic use
Indoles / therapeutic use
Lipid Metabolism / drug effects*
Risk Assessment
Risk Factors
Chemical
Reg. No./Substance:
0/Cholesterol Ester Transfer Proteins; 0/Cholesterol, HDL; 0/Hypolipidemic Agents; 0/Indoles; 0/MK-0524

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  An unusual presentation of subfrontal meningioma: a case report and literature review for Foster Ken...
Next Document:  The management of pyothorax-associated lymphoma using 18F-FDG PET/CT.